|
July 2005
Moving Forward with FDA's PAT
Initiative
Genetic Engineering News (vol. 25,
number 15)
by Angelo DePalma, Ph.D
Biotech companies have been responding
slowly, steadily, but cautiously to the FDA's PAT (Process
Analytic Technology) initiative. PAT is part of the agency's
risk-based manufacturing proposal taht it hopes will propel
pharmaceutical and biotech manufacture into the modern age.
July 2005
Peptide Manufacturers See Increased Growth
Genetic Engineering News (vol. 25, number 13)
by Vicki Glaser
Lou Bellafiore, President of TechniKrom, explains the applications of Apadtive P.A.T., including buffer blending, synthesizer design, and dynamic axial compression columns.
Adaptive P.A.T. is the company's real-time application of PAT to the process of peptide synthesis and purification. "The payback for our clients is both reduced regulatory oversight, by demonstrating true process knowledge and control, and increased yield of product, which can create a return on investment during the first run," says Bellafiore.
June 2005
New Developments in Purification Technologies
Genetic Engineering News (vol. 25, number 11)
by Angelo DePalma, Ph.D
"Interest in protein pruification has grown exponentially since completion fo the human genome project. Researchers operating at the milligram protien scale, and manufacturers prodicing hundreds of kilograms per year share a short wish list: purity and activity.
"'The FDA's recent initiative for science-based process controls to displace the incumbent approach of extensive end-of-process product QC now vindicates our approach [of adaptive P.A.T.],' says John Walker, VP of engineering. 'This demands a different class of equipment than most of those in current use since equipment based variability is part of the problem.'
"TechniKrom's buffer dilution/blending system manages rapid blending of a relatively small volume at a time, monitoring composition from co-streaming feedstocks at millisecond intervals, and using feedback control to finely adjust the control in real-time."
June 2005
Liquid Mixing: Solid Challenges
Pharmaceutical Manufacturing
by Angelo DePalma, Ph.D
"Bioprocess Chromatography is considered a high-risk operation because of variability in columns, chromatography resins and packing, and buffer flow and composition. TechniKrom, Inc. (Evanston, Ill.) has developed modular process skids which, through an innovative mix-and-measure scheme, minimize buffer variability. The idea: eliminating controllable variability (buffer composition) allows greater vigilance, and feedback, over more intractable sources of error.
"'We learned very early to focus on accurate, low variability blending, since in LC applications such as protein separations a very small change in the mobile phase has a big impact on quality,' says John Walker, VP of engineering. 'Only when the controllable variability elements have been driven out of a process can a developer clearly determine the underlying effects of the remaining parameter, and then design the appropriate process controls to guarantee quality by design.'"
View entire article on Pharmaceutical Manufacturing website
Click to go to Pharmaceutical Manufacturing Website.
March 2005
Buyers Guide - Product News
Pharmaceutical Processing
Upgraded Biochromatography
Systems Feature Improved Accuracy, Reproducibility And Compliance
View
article on Pharmaceutical Processing website
Click to go to Pharmaceutical Processing Website.
December 2004
Process Analytical Technology –
PAT Blending System Helps Control Mobile-Phase Variation
Pharmaceutical Technology
by Kaylynn Chiarello
A review of how TechniKrom has integrated
its process analytical technology into benchtop bioprocess
and HPLC chromatography systems, and how the technology reduces
both variability and eliminates the risk for fatal errors.
View
article on Pharmaceutical Technology website (scroll to last page)
Click to go to Pharmaceutical Technology Website.
December 2004
Bioprocessing: A Critical Look at
Bioproduction Approaches
Genetic Engineering News
by Angelo DePalma, Ph.D
Much has been written about biomanufacturing’s
failure to keep up, technologically, with the complexities
of and demand for biotech products. According to a survey
by Ajaz Hussain, Ph.D., a deputy director at the FDA, biotech’s
manufacturing efficiency is around 25%—far lower than
in other process industries. While innovation has traditionally
lagged due to regulatory uncertainty, comfortable profit margins
shielded biotech from its production inefficiencies. Now,
with the FDA encouraging innovation through risk-based manufacturing
and process analytics, and with biogenerics looming, biotechnology
can no longer be satisfied with business as usual. TechniKrom’s
president and CSO, Lou Bellafiore, discusses the use of Adaptive
PAT in downstream processing.
July 2004
Blend Controls Boost LC Performance
Pharmaceutical Manufacturing
by Chris DeMello, Centocor, and Lou Bellafiore and John Walker,
TechniKrom, Inc.
A review with a case study of how Adaptive
PAT™ (Process Analytical Technology) reduces reagent
variability and improves liquid chromatography efficiency.
View
article on Pharmaceutical Manufacturing website
Click
to go to Pharmaceutical Manufacturing Website.
June 1, 2004
Bioprocessing: The Changing Oligonucleotide
Marketplace
Genetic Engineering News
As price wars exert pressure to drive
oligo prices lower, oligo manufacturers are relying on product-quality
measures, delivery time, reputation, and product range to
separate themselves from their competition. John Walker, TechniKrom’s
VP of Engineering, discusses how the use of Adaptive PAT can
be used to improve productivity and manufacturing costs in
oligonucleotide synthesis.
December, 2003
Cambrex Bio
Science Adds Services & Capacity
Genetic Engineering News (vol. 23, number 21)
by Peter Tunon
Cambrex Bio Science has added to its range of contract development
and manufacturing services. TechniKrom's LC chromatography
system provided the necessary mobile-phase blending and gradient
control, while the adaptive dynamic axial compression columns
provided the ease of use and reproducibility Cambrex was looking
for.
View
PDF of December 2003 Genetic Engineering News article
January 1, 2003
Bioprocessing
Tutorial: Applying "Six Sigma" to Chromatography
Genetic Engineering News (vol. 23, number 1)
by Kevin Henretta, John Walker and Lou Bellafiore
By using Six Sigma to systematically identify and eliminate
the sources of unnecessary variability in preparative liquid
chromatography (LC) processes, it is possible to dramatically
cut the cost of today's mainstream LC approaches while at
the same time improving product quality and providing insurance
against potentially catastrophic process failures. The article
concentrates on the need for, and creation of, highly accurate
and reproducible LC delivery systems in order to achieve world-class
production scale LC performance resulting in lower production
costs.
View
PDF of Janaury 1, 2003 Genetic Engineering News article
October 15, 2002
Advances in Preparative Chromatography
Genetic Engineering News (vol. 22, number 18)
by Peter Tunon
Article provides an overview of the
PREP 2002 Symposium at which TechniKrom exhibited, sponsored,
and presented. TechniKrom is highlighted on page 18 mentioning
firms utilizing a Six Sigma approach to uncover the hidden
costs of large scale LC, its equipment providing isocratic
and gradient mobile phase blending within 0.1% accuracy throughout
full scale, versus the industry standard of 2-5% accuracy
within a "sweet spot". Equipment offers 20- to 50-fold improvement
in reproducible accuracy which has significant impact on process
economics through increased product purity, recovery, and
throughput, especially in FDA regulated environments with
high value added products. Pay back on equipment investment
is possible in a single purification for both clinical and
commercial products. New 21 CFR Part 11 capable control software
and many other features of columns and system skid are also
discussed.
September 30, 2002
A Peak at HPLC
The Scientist
by Jeremy Peirce
The article begins on page 47 and provides
a review of high-performance liquid chromatography techniques.
Firm's president, Lou Bellafiore, comments on some of the
causes of backpressures generated within an HPLC system.
View
article on The Scientist website (membership required)
Click
to go to The Scientist Magazine Website.
November 11, 2002
TechniKrom expanding services with
contract purification for pharmaceutical and biopharmaceutical
manufacturing
Press Release
Evanston, IL, November 11, 2002: TechniKrom
Inc., a leading chromatography supplier for pilot scale and
manufacturing, announced today an expansion of its contract
services, with the addition of pilot scale and small scale
chromatography purification. "We are now in a positition to
help a client all the way from process development and validation
of that process, through contract manufacturing", says Lou
Bellafiore, President and CEO. Small and responsive, with
expertise in systems engineering and in developing processes
for the manufacture of pharmaceutical compounds, therapeutic
proteins, small organic molecules, oligonucleotides and peptides,
TechniKrom can help companies quickly develop, design and
implement a cost effective separation process. The company's
multi-purpose facility maintains automated analytical and
preparative LC systems, dynamic axial compression columns,
and has a total manufacturing capability up to kilogram quantities.
Larger quantities purified under GLP or cGMP conditions are
also available as is access to a class 10,000 cleanroom.
TechniKrom now offers a full range
of both analytical and preparative services. The company can
develop analytical assays to support discovery, clinical trials,
process monitoring, formulation, quality control, and stability
testing. It can now assist in a wide variety of manufacturing
processes including full scale preparative purification of
new compounds, isolation of impurities, and clean-up of natural
products or synthetic intermediates.
With this expansion of the purification
services the company's contract service mix is now perfectly
tailored to developmental and early production needs of pharmaceutical,
biotech, and fine chemical product development. It is TechniKrom's
intention to complement the needs of the customers, and function
as an extension of late stage research and early manufacturing.
"We can get a manufacturing process up and running without
a customer having to invest in a manufacturing facility",
says Bill Paradise, executive vice-president business development
"We are also in a position to to quickly step in and provide
additional manufacturing capacity if demand for a product
grows faster than expected. We work closely with our customers
to both optimize the economy and throughput of a process,
but we also work hard to control and reduce the environmental
impact of our processes."
TechniKrom provides comprehensive
IQ/OQ validation documentation packages, which are widely
regarded as best in the industry. The validation packages
are designed to meet FDA recommended protocols and requirements
and reduce validation timelines from months to days. The packages
come complete with all component manuals, test certificates
and documentation and provide detailed testing reports on
all validation procedures. Founded and managed by Lou Bellafiore,
president and CEO TechniKrom, Inc., headquartered in Evanston,
IL, is a privately held corporation dedicated to providing
technologically advanced products and services to users of
liquid chromatography. The company supplies the most advanced,
reproducible chromatography manufacturing equipment and columns
available for preparative work and full-scale manufacturing.
TechniKrom has customers among the top US firms within the
pharmaceutical, biotechnology, biopharmaceutical and fine
chemical industries.
Managed and run by experts in liquid
chromatography and engineering, the company has extensive
experience working with engineering, development, and construction
in the industry. TechniKrom is actively engaged in working
with Six-sigma, a disciplined and customer-focused approach
to continuous improvement of processes and products, and is
now working toward ISO9001:2000 certification.
|
|